First joint guidelines address cardiovascular events and chronic kidney disease
The first-ever European Society of Cardiology Guidelines on the management of cardiovascular disease and chronic kidney disease have…
FDA Approves Mannkind’s At-Home Treatment Option for Heart Failure or Kidney Disease
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Mannkind…
Experts urge focus on prevention to tackle global heart failure
Heart failure already affects more than 60 million people worldwide and is one of the leading causes of…
Study links oxalate to systemic inflammation and heart damage
Oxalic acid might do more than just contribute to the formation of kidney stones — it may also be an…
Updated ABCs framework gives clinicians a clearer path to prevent heart disease
From PREVENT™ risk scoring to CKM care and healthy aging, the updated ABCs framework turns complex cardiovascular guidance…
Severe gum disease linked to early kidney function decline
A growing body of research suggests that the effects of periodontitis extend far beyond the mouth. In a…
Are People With Eating Disorders Misusing GLP-1 Drugs?
Among over 400 people with eating disorders in an interim analysis of an ongoing cross-sectional study, 32.1% said…
EULAR 2026 highlights rising comorbidity risks in rheumatic disease
People with rheumatic and musculoskeletal diseases (RMD) are at risk of a number of comorbidities, from cardiovascular diseases…
Semaglutide and Ozempic-like drugs may improve kidney disease outcomes
Semaglutide — a medication commonly sold as Ozempic or Wegovy — is typically associated with weight loss. But…
GLP-1 drugs promise wider health benefits, but experts urge caution on use
As GLP-1 receptor agonists move beyond blood sugar and weight loss, a new review shows why clinicians must…
People warned to avoid reliance on drugs like ibuprofen for pain relief
People have been urged to be cautious of relying on anti-inflammatory drugs such as ibuprofen for pain relief…
How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?
A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful…